Yorkshire-based One Health Group, a key independent provider of surgical services to the NHS, has delivered strong results in its latest annual Quality Accounts Report. Among its notable statistics, 98%
Poolbeg Pharma plc (LON: POLB), a clinical-stage biopharmaceutical company focussed on the development and commercialisation of innovative medicines targeting diseases with a high unmet medical need, has announced its unaudited interim results for
Specialist research group hVIVO has seen a significant rise in revenue for the first half of 2024, recording a 30.6% increase compared to the same period last year. The company
Government plans to reduce the hospital backlog in England are facing criticism from health leaders, who argue that reforming how services are delivered is crucial for success. Labour’s strategy to
Clinical trials play a pivotal role in advancing the medical industry by allowing new treatments and interventions to be rigorously tested for both effectiveness and safety. Understanding how clinical trial
Aptamer Group plc (LON:APTA), the developer of novel Optimer® binders to enable innovation in the life sciences industry, has announced the appointment of Tim Sykes to its Board of Directors as a
Hvivo, previously known as Open Orphan, saw a significant increase in earnings during the first six months of the year, marking a 67.6% rise. Earnings before interest, taxes, depreciation, and
Children across the UK are experiencing significant health issues due to prolonged delays in receiving NHS care. Conditions such as chronic pain, asthma, weight loss, and developmental problems are becoming
The medtech industry is at a crucial point, experiencing significant growth driven by the Covid-19 pandemic, which spurred a wave of innovation and investment. Though the sector has now returned
A recent study has revealed that one in three Britons is now living with multiple illnesses, and GPs are struggling to keep up with the growing demand. An analysis of
© 2024 – DirectorsTalk. All rights reserved. Reproduction in whole or in part, in any form or medium without express written permission is prohibited.
